FindTrial
Sign In

Prednisolon 1 mg JENAPHARM

DRUG3 trials

Sponsors

Insel Gruppe AG, AbbVie Deutschland GmbH & Co. KG, Klinikum der Universitaet Muenchen AöR

Conditions

Focal cerebral arteriopathy and childhood stroke Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection.Giant Cell ArteritisPatients with biopsy-proven virus-negative inflammatory dilated or nondilated left ventricular cardiomyopathy and persistent deterioration of cardiac function despite optimal medical treatment (OMT) for heart failure

Phase 2

A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Negative Inflammatory cardiomyopaThY (TRINITY trial)
CompletedCTIS2024-512451-20-00
Klinikum der Universitaet Muenchen AöRPatients with biopsy-proven virus-negative inflammatory dilated or nondilated left ventricular cardiomyopathy and persistent deterioration of cardiac function despite optimal medical treatment (OMT) for heart failure
Start: 2023-02-28End: 2025-04-14Target: 130Updated: 2024-10-14

Phase 3

High Dose Steroids in Children with Stroke and Unilateral Focal Arteriopathy: A Multicentre Randomized Controlled Trial
Not yet recruitingCTIS2022-500631-36-00
Insel Gruppe AGFocal cerebral arteriopathy and childhood stroke Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection.
Target: 45Updated: 2025-11-14
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
CompletedCTIS2023-505476-29-00
AbbVie Deutschland GmbH & Co. KGGiant Cell Arteritis
Start: 2019-04-05End: 2025-02-24Target: 201Updated: 2024-10-28